Skip to main content

IDI2 293T Cell Transient Overexpression Lysate

Novus Biologicals, part of Bio-Techne | Catalog # H00091734-T02

Novus Biologicals, part of Bio-Techne
Discontinued Product
H00091734-T02 has been discontinued. View all IDI2 products.

Key Product Details

Species

Human

Applications

Western Blot

Product Summary for IDI2 293T Cell Transient Overexpression Lysate

Quality control test: Transient overexpression cell lysate was tested with Anti-PUM1antibody by Western Blot. Plasmid: pCMV-IDI2 full-length

Product Specifications

Specificity

IDI2 293T Cell Transient Overexpression Lysate(Denatured)

Type

293T Cell Transient Overexpression

Protein State

Denatured

Formulation, Preparation, and Storage

Formulation

1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)

Concentration

mg/ml

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.

Storage

Store at -80C. Avoid freeze-thaw cycles.

Background: IDI2

IDI2 catalyzes the attachment of glutamate to tRNA(Glu) in a two-step reaction: glutamate is first activated byATP to form Glu-AMP and then transferred to the acceptor end of tRNA(Glu)

Alternate Names

diphosphate dimethylallyl diphosphate isomerase 2, EC 5.3.3.2, IPP isomerase 2, IPPI2isopentenyl-diphosphate Delta-isomerase 2, Isopentenyl pyrophosphate isomerase 2, isopentenyl-diphosphate delta isomerase 2

Gene Symbol

IDI2

Additional IDI2 Products

Product Documents for IDI2 293T Cell Transient Overexpression Lysate

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for IDI2 293T Cell Transient Overexpression Lysate

This product is produced by and distributed for Abnova, a company based in Taiwan.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Lysates are guaranteed for 6 months from date of receipt.

Loading...
Loading...
Loading...
Loading...